News Archive

Resurvey: phase two progress report

May 15, 2014 9:00 AM

The second phase of the China Kadoorie Biobank’s second resurvey involves ~12,000 participants from 5 study areas and is progressing well.

Completion of pilot COPD adjudication project

Apr 1, 2014 9:00 AM

The pilot phase of work by the China Kadoorie Biobank to assess the quality of diagnosis of COPD cases obtained from health insurance database has been completed for ~1,100 randomly selected cases from all the ten regional centres.

Design of CKB genotyping array completed

Mar 30, 2014 9:00 AM

In collaboration with genotyping microarray manufacturer Affymetrix and our genomics partner in China, BGI-Shenzhen, the China Kadoorie Biobank team has completed the design of a low cost biobanking genotyping array optimised for Chinese populations.

Striking changes in women’s reproductive characteristics in China

Mar 17, 2014 12:00 PM

China has experienced major social and economic changes over the last several decades, and data from the China Kadoorie Biobank, published online in the International Journal of Epidemiology, showed striking changes in women’s reproductive factors over this period.

Substantial under-use of effective secondary preventive treatments among individuals with cardiovascular diseases

Dec 28, 2013 12:00 PM

Little is known about the long-term use of various proven secondary preventive treatments among patients with cardiovascular diseases (CVD) in the general Chinese population. Findings from the China Kadoorie Biobank cross-sectional data, published online in the Journal of International Cardiology on December 28, 2014, showed that only 1 in 3 individuals with a history of physician-diagnosed CVD received any of the established secondary preventive treatments (eg, aspirin, statins, beta-blockers, diuretics, ACE-I, or calcium-channel blockers). These results should help inform disease prevention and effective delivery of health care service in China.